id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-5743-0026,FDA,FDA-2019-D-5743,"Importation of Certain Food and Drug Administration-Approved Human Prescription Drugs, Including Biological Products, and Combination Products Under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability",Notice,Notice of Availability,2020-10-01T04:00:00Z,2020,10,2020-10-01T04:00:00Z,,2020-10-01T15:50:08Z,2020-21521,0,0,09000064848abac6
FDA-2019-D-5743-0003,FDA,FDA-2019-D-5743,"Importation of Certain Food and Drug Administration-Approved Human
Prescription Drugs, Including Biological Products, Under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for
Industry; Availability; Correction",Notice,Correction,2019-12-30T05:00:00Z,2019,12,2019-12-30T05:00:00Z,2020-02-22T04:59:59Z,2020-02-22T02:01:09Z,2019-28141,0,0,0900006484256d94
FDA-2019-D-5743-0001,FDA,FDA-2019-D-5743,"Importation of Certain Food and Drug Administration-Approved Human
Prescription Drugs, Including Biological Products, Under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for
Industry; Availability",Notice,Notice of Availability,2019-12-23T05:00:00Z,2019,12,2019-12-23T05:00:00Z,2020-02-22T04:59:59Z,2020-02-22T02:00:34Z,2019-27475,0,0,0900006484248282
FDA-2019-D-5743-0002,FDA,FDA-2019-D-5743,"Importation of Certain Food and Drug Administration-Approved Human
Prescription Drugs, Including Biological Products, Under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for
Industry",Other,Guidance,2019-12-23T05:00:00Z,2019,12,2019-12-23T05:00:00Z,2020-02-22T04:59:59Z,2024-11-12T23:14:43Z,,1,0,090000648424b541